Results 191 to 200 of about 684,407 (306)

Next‐generation proteomics improves lung cancer risk prediction

Molecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj, Clara Frick, Ben Schöttker, Bernd Holleczek, Hermann Brenner   +4 more
wiley   +1 more source

Reporting Vietnam. Media and military at war - W. M. Hammond.

Tijdschrift voor Mediageschiedenis, 2002
Ten Cate, Arthur
doaj   +1 more source

Toward a humanized technology: a reinterpretation of Erich Fromm' s humanistic peace psychology. [PDF]

Front Psychol
Wang Y, Li P, Liu W.
europepmc   +1 more source

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

Molecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak, Karolina Pytlak, Sandra Jaworowska, Bogusz Kulawiak, Piotr Bednarczyk   +4 more
wiley   +1 more source

The effects of war on digital adherence technology engagement for TB treatment in Ukraine. [PDF]

IJTLD Open
Deyanova N, McQuaid CF, Kochanov V, Bogdanov A, Madden N, Charalambous S, van Kalmthout K, Jerene D, Fielding KL, Gamazina K.   +9 more
europepmc   +1 more source

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

Molecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute, Júlia Huguet‐Pradell, Jordi Abril‐Fornaguera, Albert Gris‐Oliver, Alex Rialdi, Elisa Fernández‐Martínez, Carla Montironi, Vanessa Del Pozo, Peter Houghton, Laura Zanatto, Agavni Mesropian, Ieva Keraite, Swan Thung, Carolina Armengol, Pau Sancho‐Bru, Ernesto Guccione, Roser Pinyol, Josep M. Llovet   +17 more
wiley   +1 more source

Cancer care in wartime Ukraine: disruption, resilience and recovery. [PDF]

BMJ Oncol
Karavska A, Kizub D, Kovalchuk N, Brovchuk S, Sokolovska M, Nikiforchin A, Melnitchouk N.   +6 more
europepmc   +1 more source

Exploiting metabolic adaptations to overcome dabrafenib treatment resistance in melanoma cells

Molecular Oncology, EarlyView.
We show that dabrafenib‐resistant melanoma cells undergo mitochondrial remodeling, leading to elevated respiration and ROS production balanced by stronger antioxidant defenses. This altered redox state promotes survival despite mitochondrial damage but renders resistant cells highly vulnerable to ROS‐inducing compounds such as PEITC, highlighting redox
Silvia Eller, Susanne Ebner, Carmen Haselrieder, Julia K. Günther, Astrid Drasche, Sophie Strich, Chiara Volani, Andrea Medici, Aleksandar Nikolajevic, Alex Deltedesco, Johannes E. Sigmund, Michael J. Blumer, Martin Hermann, Johanna Vanacker, Gerald Brandacher, Eduard Stefan, Omar Torres‐Quesada, Jakob Troppmair   +17 more
wiley   +1 more source

Exposure to wartime sexual violence in Bosnia and Herzegovina: nationally representative prevalence 30 years after the 1992-1995 war. [PDF]

Confl Health
Schaub M, Greiner-Filsinger A, Henic A, Kasserra L.   +3 more
europepmc   +1 more source

Корпоративний медіа-вплив та аспекти мовного воркшопу (Corporate Media Influence and Aspects of Language Workshop) [PDF]

, 2012
Штайнгауер, Ренді (Randy Steinhauer)
core